MRFIX
Price
$66.10
Change
+$0.33 (+0.50%)
Updated
Oct 17 closing price
Net Assets
8.09B
VSTSX
Price
$313.67
Change
+$1.37 (+0.44%)
Updated
Oct 17 closing price
Net Assets
2.02T
Interact to see
Advertisement

MRFIX vs VSTSX

Header iconMRFIX vs VSTSX Comparison
Open Charts MRFIX vs VSTSXBanner chart's image
MFS Research I
Price$66.10
Change+$0.33 (+0.50%)
VolumeN/A
Net Assets8.09B
Vanguard Total Stock Mkt Idx Instl Sel
Price$313.67
Change+$1.37 (+0.44%)
VolumeN/A
Net Assets2.02T
MRFIX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
MRFIX vs. VSTSX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRFIX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. MRFIX (8.09B). VSTSX pays higher dividends than MRFIX: VSTSX (1.15) vs MRFIX (0.63). MRFIX was incepted earlier than VSTSX: MRFIX (29 years) vs VSTSX (9 years). MRFIX (0.52) is less costly to investors than VSTSX (0.01). MRFIX is a more actively managed with annual turnover of: 20.00 vs. VSTSX (2.00). MRFIX has a lower initial minimum investment than VSTSX: MRFIX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 13.82 vs. MRFIX (1.36). VSTSX return over 5 years is better than : 85.01 vs. MRFIX (30.95).
MRFIXVSTSXMRFIX / VSTSX
Total Expense Ratio0.520.015,200%
Annual Report Gross Expense Ratio0.520.015,200%
Fund Existence29 years9 years-
Gain YTD10.11213.02978%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.09B2.02T0%
Annual Yield % from dividends0.631.1555%
Returns for 1 year1.3613.8210%
Returns for 3 years34.5876.1645%
Returns for 5 years30.9585.0136%
Returns for 10 years79.28N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDP3.700.27
+7.87%
Indaptus Therapeutics Inc
APPN28.150.36
+1.30%
Appian Corp
IONS73.090.02
+0.03%
Ionis Pharmaceuticals
LGO1.29-0.03
-2.27%
Largo
FDMT9.84-0.25
-2.48%
4D Molecular Therapeutics